Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - colecalciferol - tablet - 800unit

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

theramex ireland limited - colecalciferol concentrate (oily form) [vitamin d3]; calcium carbonate; risedronate sodium - effervescent granules + film-coated tablet - 35 mg & 1000 mgu/880  international unit(s) - bisphosphonates, combinations; risedronic acid, calcium and colecalciferol, sequential

Malta - angielski - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - colecalciferol - oral solution - colecalciferol 3000 iu/ml - vitamins

Australia - angielski - Department of Health (Therapeutic Goods Administration)

bio-practica pty ltd - colecalciferol -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - colecalciferol, quantity: 0.14 mg; alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: gelatin; croscarmellose sodium; butylated hydroxytoluene; colloidal anhydrous silica; sucrose; magnesium stearate; microcrystalline cellulose; povidone; medium chain triglycerides - tradenames are indicated for the treatment of: ? osteoporosis* in select patients where vitamin d supplementation is recommended,* prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture

Australia - angielski - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - colecalciferol, quantity: 0.14 mg; alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; povidone; sucrose; butylated hydroxytoluene; croscarmellose sodium; microcrystalline cellulose; gelatin; medium chain triglycerides; colloidal anhydrous silica - alendronate plus d3 70 mg/140 microgram apotex are indicated for the treatment of: osteoporosis in select patients where vitamin d supplementation is recommended, prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture

Australia - angielski - Department of Health (Therapeutic Goods Administration)

homart pharmaceuticals pty ltd - calcium carbonate, quantity: 900 mg (equivalent: calcium, qty 360 mg); colecalciferol, quantity: 5 microgram - capsule, soft - excipient ingredients: yellow beeswax; white beeswax; titanium dioxide; glycerol; gelatin; purified water; lecithin; soya oil; d-alpha-tocopherol - maintain/support bone health ; aids/assists healthy bone development/growth/building ; maintain/support bone strength ; a diet deficient in calcium can lead to osteoporosis in later life. calcium may help prevent osteoporosis when dietary intake is inadequate ; vitamin d helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency

Australia - angielski - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - calcium carbonate,colecalciferol,risedronate sodium -

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

rowex ltd - alendronate sodium trihydrate; colecalciferol - tablet - alendronic acid and colecalciferol

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

rowex ltd - alendronate sodium trihydrate; colecalciferol - tablet - alendronic acid and colecalciferol